2,3-dihydro-1H-indole compounds
The present invention relates to certain novel 2,3-dihydro-1H-indole compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, more particularly for the treatment of cancer selected from the group consisting of melanoma, acute myeloid leukemia, chronic lymphocytic leukemia, colorectal cancer, breast cancer, lung cancer, ovarian cancer, fallopian tube carcinoma, primary peritoneal carcinoma, cervical cancer, gastric cancer, liver cancer, pancreatic cancer, thyroid cancer, glioma, non-Hodgkin's lymphoma, and Hodgkin's lymphoma.
Eli Lilly and Company
A C A C C C C
A61P C07C A61K C07D C07D C07C C07D
inventional inventional inventional additional inventional additional inventional
Jolie Anne Almudena Jeffrey Daniel William Thomas Bradley Earl James Robert Gaiying Daniel Jon Jiehao
Bastian Rubio Cohen McMillen Reaman Henry Zhao Sall Chen